Norwegian renewable energy solutions provider Scatec has achieved financial closure and commenced construction on the 130MW Barzalosa solar power facility in Colombia. BTG Pactual Comercializadora de Energía, a subsidiary of Banco BTG Pactual in Brazil, previously signed a 15-year power purchase agreement (PPA) for the project. This PPA will cover approximately 85% of the projected output, with the remaining portion marketed within the Colombian electricity sector. The development involves Scatec holdi ...

Ries and joining me with the big picture here on what's going on with this market. Luke Lloyd, president and CEO of Lloyd Financial Group is with me. So, we talked yesterday about how many of the names got hit pertaining to AI and Anthropic at least was part of it as it really uh announced some breakthroughs and some concerns about cyber security, concerns about financials.Um, and so many names were caught in the crossfire from Door Dash to American Express. Um, you don't particularly love the Mag 7 names a ...

Inflation ended 2025 at 5.1%, missing the central bank’s 3% target for a fifth consecutive year, according to Clavijo. She said inflation expectations rose late in the year and increased further after the announcement of a 23.7% minimum wage increase for 2026. In January, Banco de la República raised its policy rate by 100 basis points, and Clavijo said her updated view calls for year-end inflation of 6.4% and at least 200 basis points of additional policy-rate increases, which could weigh on growth.Chief E ...

Pomelo, the Argentina-headquartered payments infrastructure firm, has secured $55m in a Series C funding round. The round was co-led by Kaszek and Insight Partners. Additional backing came from existing and new investors including Index Ventures, Adams Street Partners, S32, Endeavor Catalyst, Monashees and TQ Ventures. The latest round brings the company’s total capital raised so far to $160m. Pomelo will use the new capital to move beyond its core focus on card issuing, further develop issuing and cr ...

Core Viewpoint - The article expresses a bullish outlook on Colombia as a whole but indicates skepticism towards the oil industry and specifically the stock of EC [1]. Group 1: Analyst Background - Ian Bezek, a former hedge fund analyst, has spent a decade conducting on-the-ground research in Latin America, focusing on markets such as Mexico, Colombia, and Chile [1]. - The analyst specializes in identifying high-quality compounders and growth stocks at reasonable prices in both the US and other developed markets [1]. Group 2: Investment Group Features - The investing group, Ian's Insider Corner, offers features such as a Weekend Digest that includes new investment ideas, updates on current holdings, and macroeconomic analysis [1]. - Members have access to trade alerts, an active chat room, and direct communication with the analyst [1].

Group 1 - Amer Sports, Inc. has seen a Zacks Consensus Estimate increase of 8.3% for its current year earnings over the last 60 days [1] - Intuitive Surgical, Inc. has experienced a 5.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Pediatrix Medical Group, Inc. has had a significant increase of 15.7% in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Seanergy Maritime Holdings Corp. has seen a remarkable 66.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Grupo Cibest S.A. has experienced an 8.7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]

Core Insights - Emerson Electric Co. (EMR) is expected to report earnings and revenue growth for the fourth quarter of fiscal 2025, with revenues estimated at $4.88 billion, reflecting a 5.7% increase year-over-year [1] - The consensus estimate for earnings is $1.62 per share, indicating a 9.5% increase from the previous year, with a slight upward revision of 0.6% in the last 30 days [2] Revenue Performance - The Intelligent Devices segment is projected to see a revenue increase of 4.5% year-over-year to $3.4 billion, driven by strong performance in the final control business and recovery in the Discrete Automation business across North America and Asia, Middle East & Africa [3] - The Software and Control segment is expected to grow by 11.4% year-over-year to $1.5 billion, supported by momentum in the Control Systems & Software business and recovery in the Test & Measurement unit across the Americas and Europe [4] - Emerson anticipates underlying sales to rise approximately 5-6% year-over-year in the fiscal fourth quarter [5] Strategic Acquisitions - In March 2025, Emerson acquired the remaining shares of AspenTech, enhancing its automation portfolio and software-defined control capabilities [6] - The company completed the buyout of National Instruments for $8.2 billion in October 2023, strengthening its global automation presence and expanding into high-growth markets such as semiconductors, transportation, and aerospace [6] Cost and Margin Considerations - Rising costs and expenses due to higher input costs and restructuring actions are likely to impact EMR's margin performance [7] - Foreign currency headwinds from substantial international operations may also affect margins and profitability [7] Earnings Prediction - The current Earnings ESP for Emerson is -0.80%, indicating a lower likelihood of an earnings beat, as the Most Accurate Estimate is $1.60 per share, below the consensus estimate of $1.62 [8]

Company Performance - ITT shares have increased by 3% over the past month, reaching a new 52-week high of $197.07, and have gained 30.9% since the start of the year, outperforming the Zacks Conglomerates sector and the Zacks Diversified Operations industry, both of which have seen a -1.1% return [1] - The company has consistently exceeded earnings expectations, reporting EPS of $1.78 against a consensus estimate of $1.67 in its last earnings report on October 29, 2025, and beating revenue estimates by 2.23% [2] Earnings Forecast - For the current fiscal year, ITT is projected to achieve earnings of $6.56 per share on revenues of $3.87 billion, reflecting an 11.95% increase in EPS and a 6.48% increase in revenues [3] - The next fiscal year is expected to see earnings of $7.38 per share on revenues of $4.06 billion, indicating a year-over-year change of 12.42% in EPS and 5.03% in revenues [3] Valuation Metrics - ITT's current valuation metrics show a Price-to-Earnings (P/E) ratio of 28.5X for the current fiscal year, which is a premium compared to the peer industry average of 18.8X, and a trailing cash flow basis P/E of 24.6X versus an average of 11.5X for peers [7] - The stock has a PEG ratio of 2.28, which does not place it among the top tier of stocks from a value perspective [7] Zacks Rank and Style Scores - ITT holds a Zacks Rank of 2 (Buy) due to favorable earnings estimate revisions from analysts, meeting the criteria for selection based on Zacks Rank and Style Scores [8] - The company has a Value Score of D, a Growth Score of B, and a Momentum Score of A, resulting in a combined VGM Score of B [6] Industry Comparison - Grupo Cibest S.A. - Sponsored ADR (CIB) is a notable peer with a Zacks Rank of 1 (Strong Buy) and a Value Score of A, indicating strong performance within the industry [9] - CIB is expected to post earnings of $7.27 per share on revenues of $6.87 billion for the current fiscal year, having beaten consensus estimates by 7.83% in the last quarter [10] - The Diversified Operations industry is positioned in the top 22% of all industries, suggesting favorable conditions for both ITT and CIB [11]

Core Insights - 3M Company (MMM) reported third-quarter 2025 results with revenues and earnings exceeding the Zacks Consensus Estimate [1][10] Financial Performance - Adjusted earnings were $2.19 per share, surpassing the Zacks Consensus Estimate of $2.10, and up from $1.98 per share in the same quarter last year [2][10] - Net revenues reached $6.52 billion, reflecting a 3.5% year-over-year increase, with organic sales up 2.6% [2][10] - Adjusted revenues of $6.30 billion also beat the consensus estimate of $6.25 billion, with organic revenues increasing 3.2% year over year [3] Segment Performance - Safety and Industrial segment revenues totaled $2.92 billion, up 5.4% year over year, exceeding the consensus estimate of $2.90 billion [4] - Transportation & Electronics segment revenues were $2.19 billion, reflecting a 2.4% year-over-year increase, surpassing the consensus estimate of $1.98 billion [5] - Consumer segment revenues increased 0.9% year over year to $1.31 billion, matching the consensus estimate [6] Margin and Cost Analysis - Cost of sales increased 4% year over year to $3.79 billion, while selling, general and administrative expenses decreased 22.8% to $820 million [7] - Adjusted operating income rose 11.6% year over year to $1.56 billion, with an adjusted operating margin of 24.7% compared to 23% in the previous year [8] Balance Sheet and Cash Flow - Cash and cash equivalents at the end of the quarter were $4.7 billion, down from $5.6 billion at the end of December 2024, while long-term debt increased to $11.9 billion [11] - Generated net cash from operating activities was $723 million, significantly higher than $1 million in the year-ago quarter [11] - Adjusted free cash flow was $3.08 billion, up 13% year over year, with a conversion rate of 91% [12] 2025 Guidance - For 2025, 3M expects adjusted earnings in the range of $7.95-$8.05 per share, an increase from the previous guidance of $7.75-$8.00 [13] - Adjusted total revenues are projected to grow more than 2.5%, with adjusted organic revenue growth expected to exceed 2% [14]

Core Insights - Danaher Corporation's (DHR) third-quarter 2025 adjusted earnings were $1.89 per share, exceeding the Zacks Consensus Estimate of $1.71, marking a 10.5% year-over-year increase [1][9] - The company reported net sales of $6.05 billion, surpassing the consensus estimate of $6.00 billion, with a year-over-year growth of 4.5% across all segments [1][9] - Core sales increased by 3% year over year, with foreign-currency translations contributing positively by 1.5% [1] Segmental Performance - Life Sciences segment revenues reached $1.79 billion, a 0.5% increase year over year, although core sales decreased by 1% [2] - Diagnostics segment revenues totaled $2.46 billion, up 4% year over year, with core sales increasing by 3.5% [3] - Biotechnology segment revenues were $1.80 billion, reflecting a 9% year-over-year increase, with core sales rising by 6.5% [4] Margin and Profitability - Danaher's cost of sales rose by 5.5% year over year to $2.53 billion, while gross profit increased by 3.6% to $3.52 billion, resulting in a gross margin of 58.2% [5] - Operating profit surged by 20.5% year over year to $1.15 billion, with operating margin expanding to 19.1% from 16.5% [6] Balance Sheet and Cash Flow - At the end of the third quarter, Danaher had cash and equivalents of $1.53 billion, down from $2.08 billion at the end of 2024, with long-term debt increasing to $16.8 billion [7] - The company generated net cash of $4.30 billion from operating activities in the first nine months of 2025, compared to $4.67 billion in the same period last year [8] Future Outlook - For the upcoming quarter, Danaher anticipates adjusted core sales from continuing operations to increase in the low single digits year over year, with expected adjusted earnings between $7.70 and $7.80 per share [10]